Fundraising Fox

Alessa Therapeutics

San Carlos, US · 2 known investors

alessatherapeutics.com ↗

Alessa Therapeutics develops a proprietary drug-delivery platform for sustained and localized release of therapies to treat early-stage prostate cancer. The company is advancing Enolen, a drug-eluting implant designed to deliver enzalutamide directly to the prostate with fewer systemic side effects than existing treatments.

BiotechHealthtechMedical Devices

Founders & leadership

PM
Pamela MunsterFounder, Chief Scientific Advisor and Director

Investors · 2

Cure VenturesBoston
Mission BiocapitalSan Francisco · $500K – $500K

In the news